Adularia’s Journey Highlighted in Founded Interview
Our CEO, Dr. Ana Montalban-Arques, spoke with Founded about Adularia’s journey and our new approach in cancer therapy. The article highlights how we are harnessing microbiota-derived insights to develop a targeted small-molecule treatment.
Comments